Category Archives: News

PRESS RELEASE – Dopharma and Ripac-Labor announce Ground-breaking Ceremony for new Autogenous Vaccine Production Facility in Potsdam

Thilo Mehlhase (PBM architects), Wijnand de Brujin and Ruud de Rijke (Dopharma), Mike Schubert (Oberbürgermeister der Landeshauptstadt Potsdam), Heiko Rüdiger (RIPAC-LABOR GmbH) und Agnes von Matuschka (Standortmanagement Golm GmbH, Potsdam Science Park - ©Hartmut Bösene

Raamsdonksveer, Netherlands / Potsdam, Germany, 03 March 2025 – The Dopharma Group and its fully owned subsidiary Ripac-Labor GmbH, are pleased to announce the official ground-breaking of their new state-of-the-art production facility for autogenous vaccines in Potsdam, Germany. This took place in the presence of Mike Schubert (Oberbürgermeister Potsdam), Wijnand de Bruijn (CEO Business Dopharma […]

[PRESS RELEASE] Dopharma strengthens position in Asia with registration Melovem® 30 mg/ml Injection in China

[av_section min_height=” min_height_pc=’25’ min_height_px=’500px’ shadow=’no-border-styling’ bottom_border=’no-border-styling’ bottom_border_diagonal_color=’#333333′ bottom_border_diagonal_direction=” bottom_border_style=” padding=’default’ margin=” custom_margin=’0px’ av-desktop-custom_margin=” av-medium-custom_margin=” av-small-custom_margin=” av-mini-custom_margin=” svg_div_top=” svg_div_top_color=’#333333′ svg_div_top_width=’100′ svg_div_top_height=’50’ svg_div_top_max_height=’none’ svg_div_top_flip=” svg_div_top_invert=” svg_div_top_front=” svg_div_top_opacity=” svg_div_top_preview=” svg_div_bottom=” svg_div_bottom_color=’#333333′ svg_div_bottom_width=’100′ svg_div_bottom_height=’50’ svg_div_bottom_max_height=’none’ svg_div_bottom_flip=” svg_div_bottom_invert=” svg_div_bottom_front=” svg_div_bottom_opacity=” svg_div_bottom_preview=” color=’main_color’ background=’bg_color’ custom_bg=” background_gradient_direction=’vertical’ background_gradient_color1=’#000000′ background_gradient_color2=’#ffffff’ background_gradient_color3=” src=” attach=’scroll’ position=’top left’ repeat=’no-repeat’ video=” video_ratio=’16:9′ video_mobile_disabled=” overlay_enable=” overlay_opacity=’0.5′ overlay_color=” overlay_pattern=” […]

Press release | Introduction Melovem® 15 mg/ml

Melovem® 15 mg/ml oral suspension for pain relief in horses Raamsdonksveer 24-08-2023 – Dopharma is extending its NSAID range with Melovem® 15 mg/ml. This oral suspension is exclusively authorized for use in horses and a welcome addition to Dopharma’s well-known Melovem® 20 mg/ml injectable (I.V.) for the treatment of horses. Fast pain relief thanks to […]

Dopharma now full owner of Ripac-Labor

On 1 September 2017, Dopharma International B.V. had acquired 65% of the company shares of RIPAC-LABOR and since then, Mrs. Dagmar Köhler-Repp as managing shareholder had further developed RIPAC-LABOR together with Dopharma International B.V. Already since 2014, Dopharma International B.V. has started to gain extensive experience in the marketing, distribution and production of farm specific […]

New website: www.coophavet.com

News

In 2019 Dopharma purchased the Coophavet brand and marketing authorizations from Boehringer Ingelheim. Coophavet is a well-known brand in many countries and therefore it will be remained. With www.coophavet.com being an important resource for our customers, we redesigned the website to the Dopharma look and feel. The new Coophavet website contains basic information and shows […]

Check out the new turkeys health hub on Dopharmaforturkeys.com

Turkeys are a unique kind of poultry. In turkey production some specific facts about physiology and behaviour are important and will ask for adapted farming compared to, for instance, chickens. Dopharma has identified turkeys as a major minor species. We have seen the need for specific products in turkeys and have invested already many years […]

Corona update

News

Due to the Coronavirus pandemic, we would like to inform you that at DOPHARMA we have implemented all the measures recommended by the authorities to prevent the spread of COVID-19. We will continue providing services to our customers to guarantee the health, nutrition and wellbeing of our animals. However, some delays may be experienced due […]

Andersen and Dopharma join forces in Spain!

Andersen and Dopharma announce the signing of a Joint Venture agreement for the marketing of their veterinary pharmaceutical products in Spain through a new company named  Dopharma Iberia. Andersen, a veterinary pharmaceutical company with 45 years of experience since the beginning of its operations in Spain and export markets, also has a strong focus on […]

Dopharma
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.